Abstract-We have shown that interleukin-1 (IL-1) activates the human brain natriuretic peptide (hBNP) promoter via a transcriptional mechanism. Others have reported that changes in intracellular calcium (Ca 2ϩ ) mediate the action of IL-1. We questioned whether Ca 2ϩ and Ca 2ϩ -dependent pathways mediate IL-1 regulation of the hBNP promoter in cardiac myocytes. The hBNP promoter (Ϫ1818 to ϩ100) coupled to a luciferase cDNA reporter gene was transferred into neonatal cardiac myocytes. Cells were then treated with agents that modify Ca 2ϩ levels or inhibit Ca 2ϩ -dependent kinases, and luciferase activity was measured as an index of hBNP promoter activity. The Ca 2ϩ ionophore A23187 increased hBNP promoter activity; however, neither EGTA nor nifedipine reduced IL-1-stimulated promoter activity. Long-term treatment with thapsigargin, which depletes intracellular Ca 2ϩ stores, decreased basal promoter activity and blocked the effect of IL-1. Inhibition of protein kinase C completely blocked IL-1-stimulated hBNP promoter activity, whereas inhibition of Ca 2ϩ /calmodulin-dependent kinase II decreased promoter activity by 40%. In contrast, inhibition of the Ca 2ϩ -regulated phosphatase calcineurin by cyclosporin A had no effect. These data suggest that (1)